Albany Molecular Research... (AMRI)
NASDAQ: AMRI
· Real-Time Price · USD
21.74
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
Albany Molecular Research Revenue
Albany Molecular Research reported an annual revenue of $570.45M, reflecting a undefined% growth. For the quarter ending June 30, 2017, Albany Molecular Research generated $172.93M in revenue.
Revenue (ttm)
n/a
Revenue Growth
n/a
Price / Sales Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
0
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2016 | 570.45M | +41.78% |
| Dec 31, 2015 | 402.36M | +45.48% |
| Dec 31, 2014 | 276.57M | +12.17% |
| Dec 31, 2013 | 246.57M | +8.77% |
| Dec 31, 2012 | 226.69M | +9.17% |
| Dec 31, 2011 | 207.65M | +4.84% |
| Dec 31, 2010 | 198.07M | +0.84% |
| Dec 31, 2009 | 196.42M | -14.33% |
| Dec 31, 2008 | 229.26M | +19.09% |
| Dec 31, 2007 | 192.51M | +7.07% |
| Dec 31, 2006 | 179.81M | -2.23% |
| Dec 31, 2005 | 183.91M | +8.48% |
| Dec 31, 2004 | 169.53M | -13.66% |
| Dec 31, 2003 | 196.35M | n/a |